Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.20.1
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating expenses:    
Research and development $ 4,620 $ 2,761
General and administrative 3,275 1,229
Total operating expenses 7,895 3,990
Loss from operations (7,895) (3,990)
Other income:    
Interest income 410 458
Net loss (7,485) (3,532)
Deemed dividend   (5,326)
Net loss attributable to common stockholders $ (7,485) $ (8,858)
Net loss per share of voting and non-voting common stock, basic and diluted $ (0.33) $ (6.05)